Ornit Chiba-Falek, GCB member and associate professor of neurology, collaborated with Boris Kantor, assistant research professor in neurobiology, ... read more
Targeted genome editing as "next generation drugs" for Parkinson's disease
Targeted genome editing as “next generation drugs” for Parkinson’s disease